Histone deacetylase inhibitors: Overview and perspectives Journal Article


Authors: Dokmanovic, M.; Clarke, C.; Marks, P. A.
Article Title: Histone deacetylase inhibitors: Overview and perspectives
Abstract: Histone deacetylase inhibitors (HDACi) comprise structurally diverse compounds that are a group of targeted anticancer agents. The first of these new HDACi, vorinostat (suberoylanilide hydroxamic acid), has received Food and Drug Administration approval for treating patients with cutaneous T-cell lymphoma. This review focuses on the activities of the 11 zinc-containing HDACs, their histone and nonhistone protein substrates, and the different pathways by which HDACi induce transformed cell death. A hypothesis is presented to explain the relative resistance of normal cells to HDACi-induced cell death. Copyright © 2007 American Association for Cancer Research.
Keywords: unclassified drug; histone deacetylase inhibitor; itf 2357; clinical trial; fatigue; review; cisplatin; doxorubicin; fluorouracil; diarrhea; antineoplastic agents; clinical trials as topic; gemcitabine; paclitaxel; neoplasms; cell death; imatinib; carboplatin; unindexed drug; gene expression; anemia; etoposide; thrombocytopenia; combination chemotherapy; antineoplastic activity; drug effect; t cell lymphoma; enzyme regulation; drug mechanism; enzyme inhibitors; sulfonamide; vorinostat; trastuzumab; zinc; panobinostat; histone deacetylases; retinoid; 3 phenylsulfamoylcinnamohydroxamic acid; n (2 aminophenyl) 4 (3 pyridinylmethoxycarbonylaminomethyl)benzamide; pivaloyloxymethyl butyrate; 4 [n (2 hydroxyethyl) n [2 (3 indolyl)ethyl]aminomethyl]cinnamohydroxamic acid; sk 7041; sk 7068; depsipeptide; pci 24781; ellipticine; metalloproteins; 17 allylamino 17 demethoxygeldanamycin; fr 901228; if 2357; lbh 589; mgcd 0103; pdx 101
Journal Title: Molecular Cancer Research
Volume: 5
Issue: 10
ISSN: 1541-7786
Publisher: American Association for Cancer Research  
Date Published: 2007-10-01
Start Page: 981
End Page: 989
Language: English
DOI: 10.1158/1541-7786.mcr-07-0324
PUBMED: 17951399
PROVIDER: scopus
DOI/URL:
Notes: --- - "Cited By (since 1996): 175" - "Export Date: 17 November 2011" - "CODEN: MCROC" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Cathy Clarke
    2 Clarke
  2. Paul Marks
    186 Marks
Related MSK Work